Health News
Sex Makes a Difference in Cancer
Did you know that women who have cancer are more likely to outlive men with the disease? This is true for a variety of cancers. In terms of the worst form of skin cancer, women have an advantage that's not fully understood.
FDA Approves Two New Melanoma Rx
Melanoma, the most dangerous form of skin cancer, now has two new enemies. The FDA has approved two drugs to treat melanoma that has spread to other organs (metastatic) or can’t be surgically removed.
FDA Approves Two Drugs, Companion Diagnostic Test for Advanced Skin Cancer
The US Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
Happy "Don't Fry Day"
As summer approaches and you start to enjoy more outdoor activities, you’ll want to protect yourself and your kids from the sun’s damaging rays. Do you know which sunscreen to select?
Not Your Garden Variety Skin Cancer
Skin cancers that are not melanoma are typically curable. A common type of skin cancer, though, can spread and become lethal, new research has found.
Cutting the Cancer Costs of Indoor Tanning
More than two million Americans learn they have skin cancer every year. And the most serious form of skin cancer – melanoma – kills more than 9,000 people in the US each year.
Indoor Tanners Be Warned
Indoor tanning is a dangerous practice. Why? Because the artificial rays, like the sun itself, increase the risk of skin cancer, including deadly melanoma.
FDA Issues Proposal to Increase Consumer Awareness of Tanning Bed Risks
Today, the US Food and Drug Administration issued a proposed order that, if finalized, would reclassify sunlamp products and require labeling to include a recommendation designed to warn young people not to use these devices.
Trametinib US PDUFA Date Extended to September 2013
GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, its MEK inhibitor, has been extended by 3 months to 3 September 2013.
Too Frail for Cancer Surgery
You have a one in five chance of getting skin cancer at some point in your life. We all do. How elderly skin cancer patients are treated is now being called into question.